Buccal Micronuclei Assay as a Tool For Biomonitoring DNA Damage in Oral Lichen Planus
Author(s) -
Vidyalakshmi Santhanam,
R Madhavan Nirmal,
Veeran Veeravarmal,
A Santhadevy,
R Aravindhan,
Sumathy
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/17074.8072
Subject(s) - micronucleus test , buccal administration , oral lichen planus , micronucleus , buccal swab , field cancerization , pathology , dermatology , medicine , biology , cancer , microbiology and biotechnology , dentistry , toxicity
The malignant transformation rate of Oral Lichen Planus (OLP) is between 0% and 5.8%. Oral lesions of lichen planus clinically presents itself multifocally, simulating the process of field cancerization in high risk malignancies. The Buccal MicroNucleus Cytome Assay (BMN Assay) provides a platform to identify the high risk individuals by evaluating the markers of nuclear damage at an earliest micro invasive phase.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom